HVC
Healthcare Value Capital Portfolio holdings
AUM
$38.5M
This Quarter Return
+7.6%
1 Year Return
+22.29%
3 Year Return
+31.09%
5 Year Return
+125.72%
10 Year Return
–
AUM
$60.6M
AUM Growth
+$60.6M
(-5.9%)
Cap. Flow
-$27.2M
Cap. Flow
% of AUM
-44.81%
Top 10 Holdings %
Top 10 Hldgs %
64.59%
Holding
58
New
9
Increased
4
Reduced
7
Closed
11
Top Buys
| 1 |
HNT
HEALTH NET INC
HNT
|
$3.17M |
| 2 |
Merck
MRK
|
$2.38M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$1.89M |
| 4 |
SLTM
SOLTA MED INC (DE)
SLTM
|
$1.85M |
| 5 |
Gyre Therapeutics
GYRE
|
$1.08M |
Top Sells
| 1 |
ANI Pharmaceuticals
ANIP
|
$16.5M |
| 2 |
Accuray
ARAY
|
$3.89M |
| 3 |
Cardinal Health
CAH
|
$3.3M |
| 4 |
Bio-Techne
TECH
|
$2.76M |
| 5 |
Orthofix Medical
OFIX
|
$1.92M |
Sector Composition
| 1 | Healthcare | 78.61% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Supernus Pharmaceuticals
SUPN
$2.53B
| $6.35M | 5.55% | 865,745 +143,431 | +20% | +$1.05M |
|
|
2
ANI Pharmaceuticals
ANIP
$2.03B
| $5.41M | 4.73% | 554,088 -1,690,575 | -75% | -$16.5M |
|
|
AUXL
3
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $5.18M | 4.53% | 284,481 +10,000 | +4% | +$182K |
|
4
AstraZeneca
AZN
$248B
| $4.27M | 3.73% | 82,239 | – | – |
|
5
Quest Diagnostics
DGX
$20.3B
| $4.15M | 3.63% | 67,208 | – | – |
|
|
6
Merck
MRK
$210B
| $3.19M | 2.79% | 67,000 +50,000 | +294% | +$2.38M |
|
|
HNT
7
DELISTED
HEALTH NET INC
HNT
| $3.17M | 2.77% | +100,000 | New | +$3.17M |
|
|
FRX
8
DELISTED
FOREST LABORATORIES INC
FRX
| $3.01M | 2.63% | 70,382 -15,000 | -18% | -$642K |
|
9
GSK
GSK
$79.9B
| $2.31M | 2.02% | 45,966 | – | – |
|
|
GIVN
10
DELISTED
GIVEN IMAGING LTD
GIVN
| $2.11M | 1.85% | 109,950 | – | – |
|
|
QLTI
11
DELISTED
QLT Inc
QLTI
| $1.92M | 1.68% | 415,139 +50,000 | +14% | +$231K |
|
|
12
Teva Pharmaceuticals
TEVA
$21.1B
| $1.89M | 1.65% | +50,000 | New | +$1.89M |
|
13
Humana
HUM
$36.5B
| $1.87M | 1.63% | 20,000 -20,100 | -50% | -$1.88M |
|
|
SLTM
14
DELISTED
SOLTA MED INC (DE)
SLTM
| $1.85M | 1.62% | +892,250 | New | +$1.85M |
|
|
AGN
15
DELISTED
Allergan plc
AGN
| $1.8M | 1.58% | 12,524 | – | – |
|
16
Sanofi
SNY
$121B
| $1.66M | 1.45% | 32,735 | – | – |
|
|
SGNT
17
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $1.51M | 1.32% | 73,822 -29,100 | -28% | -$594K |
|
18
Elevance Health
ELV
$71.8B
| $1.25M | 1.1% | 15,000 -7,638 | -34% | -$639K |
|
|
19
Gyre Therapeutics
GYRE
$703M
| $1.08M | 0.94% | +202,600 | New | +$1.08M |
|
20
Pacira BioSciences
PCRX
$1.2B
| $986K | 0.86% | 20,500 -24,500 | -54% | -$1.18M |
|
21
Artivion
AORT
$2.07B
| $828K | 0.72% | 118,288 | – | – |
|
|
VXRT
22
DELISTED
Vaxart
VXRT
| $758K | 0.66% | +181,229 | New | +$758K |
|
|
STML
23
DELISTED
Stemline Therapeutics, Inc.
STML
| $746K | 0.65% | +16,464 | New | +$746K |
|
24
Neurocrine Biosciences
NBIX
$13.8B
| $566K | 0.49% | +50,000 | New | +$566K |
|
|
ZGNX
25
DELISTED
Zogenix, Inc.
ZGNX
| $511K | 0.45% | 276,336 | – | – |
|